AJR ARRS Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laniado, M
Right arrow Articles by Felix, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laniado, M
Right arrow Articles by Felix, R
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
American Journal of Roentgenology, Vol 150, Issue 4, 817-821
Copyright © 1988 by American Roentgen Ray Society


Articles

MR imaging of the gastrointestinal tract: value of Gd-DTPA

M Laniado, W Kornmesser, B Hamm, W Clauss, HJ Weinmann, and R Felix

Department of Radiology, Freie Universitat Berlin, W. Germany.

To determine the value of gadolinium-DTPA (Gd-DTPA) as an MR contrast material for the gastrointestinal tract, we obtained T1-, T2-, and proton-density-weighted MR scans of the abdomen in 20 volunteers before and after oral administration of the compound (10 ml/kg of a 0.5- or 1.0-mM solution). Gd-DTPA was given either alone or with mannitol (15 or 30 g/l). Opacification of the small bowel after the administration of 1.0 mM Gd-DTPA was superior to that achieved after administration of the 0.5-mM solution. In the absence of Gd-DTPA, the pancreas could be delineated partly in 11 cases. After administration of Gd-DTPA, the pancreas could be well differentiated from stomach and duodenum in 16 of 20 cases. In the absence of mannitol, two of the five subjects had homogeneous opacification of the entire small bowel. When Gd-DTPA was given with either 15 or 30 g mannitol/l, homogeneous opacification of the entire small bowel was obtained in nine of 10 volunteers. Diarrhea not discomforting to the volunteers was noted in four of 20 cases. No abnormal blood tests were recorded after administration of Gd-DTPA. The results suggest that oral administration of Gd-DTPA (1.0 mM) given with mannitol (15 g/l) is effective as an MR contrast agent for the gastrointestinal tract. The formulation was found to be safe in a small series of 20 volunteers.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
G. Antoch, H. Kuehl, J. Kanja, T. C. Lauenstein, H. Schneemann, E. Hauth, W. Jentzen, T. Beyer, S. C. Goehde, and J. F. Debatin
Dual-Modality PET/CT Scanning with Negative Oral Contrast Agent to Avoid Artifacts: Introduction and Evaluation
Radiology, March 1, 2004; 230(3): 879 - 885.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
R. A. Kubik-Huch, N. M. Gottstein-Aalame, T. Frenzel, B. Seifert, E. Puchert, S. Wittek, and J. F. Debatin
Gadopentetate Dimeglumine Excretion into Human Breast Milk during Lactation
Radiology, August 1, 2000; 216(2): 555 - 558.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Roentgen Ray Society.